Welcome to PsychU!

Schizophrenia: Fast Facts

You must be logged-in to view this content.

Social Cognitive Impairment Similar In Schizophrenia & Autism

Those with “schizophrenia spectrum disorders” (SSDs) and those with “autism spectrum disorder” (ASD) have similar levels of social cognitive impairment. …

You must be logged-in to view this content.

Log In

Frequent Psychiatric Hospitalization Is Highest Among Those With Schizophrenia

The odds of becoming a “high utilizer” of psychiatric hospital services are highest among those with schizophrenia, at 111% higher. …

You must be logged-in to view this content.

The STARR Coalition Seeks To Destigmatize Mental Health Research Through Innovative Initiatives & Programs

Join Luke Kramer, Executive Director of the Starr Coalition, as he discusses stigma involved in mental health research, goals for …

You must be logged-in to view this content.

Digital Technologies For Schizophrenia

Dr. Brian Kirkpatrick, MD, MSPH, Chair of Psychiatry and Behavioral Sciences at the University of Nevada, Reno School of Medicine, …

You must be logged-in to view this content.

Telemedicine & Medication Adherence

Nonadherence to psychotropic medication is one of the major obstacles when treating mental illnesses. Approximately 60% of individuals diagnosed with …

You must be logged-in to view this content.

Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

You must be logged-in to view this content.

PANSS-6: A Tool For Measure-Based Care In Schizophrenia

You must be logged-in to view this content.

Effects Of Brain-Derived Neurotrophic Factor & C-Reactive Protein On Cognitive Impairment In Schizophrenia: Existing Evidence

You must be logged-in to view this content.

Mental Health Education Roundtable: A Collaborative Discussion Among A Parent, Advocate & Educator: Follow-Up Q&A

During this question-and-answer session, Jessica Hull, MS, Amy Molloy, MSW, and Michael Townsend, MA, LMSW, respond to unanswered questions from …

You must be logged-in to view this content.

CooperRiis Launches New Intensive Clinical Program For Mental Health & Addiction Treatment

You must be logged-in to view this content.

Household Size & Employment Status Are Key Factors In Mental Health Among Canadians During COVID-19

You must be logged-in to view this content.

“I’m Here…”: Helping Those With Mood Disorders

You must be logged-in to view this content.

Suicide Rate For People With Schizophrenia Disorder Is 1.7% During 10 Years Post-Diagnosis

About 1.7% of people first diagnosed with a schizophrenia spectrum disorder (SSD) died by suicide. During the 10 years post-diagnosis, …

You must be logged-in to view this content.

Navigating Telepsychiatry In Mental Health Care: A Discussion With A Peer Specialist & A Caregiver

On average, in the United States there is one mental health provider for every 536 individuals, and providers are not …

You must be logged-in to view this content.

The EARLY Clinic Program: Treating First-Episode Psychosis

You must be logged-in to view this content.

Population Density & Genetic Risk For Schizophrenia

You must be logged-in to view this content.

Examining The Relationship Between Psychotic Experiences & Suicidal Behaviors

Introduction
Over the last 20 years, researchers have extensively delved into psychotic experiences in the general population. While these hallucinatory experiences …

You must be logged-in to view this content.

Follow-Up Mental Health Visits Lower Among Those With Substance Addiction

Follow-up mental health visits, within 14 days after emergency department contact, are lower among those with substance addiction than those …

You must be logged-in to view this content.

Mental Health Education: A Discussion With A Psychiatrist

This podcast features Madhukar Trivedi, MD, and Kim Lonergan, RN, MSN, discussing mental health education around the globe. Their conversation …

You must be logged-in to view this content.

Addcounsel Launches Orchestrate Health, At-Home Mental Health Care Service In UK

You must be logged-in to view this content.

Interacting With First Responders Webinar: Follow-Up Q&A Podcast

Elizabeth DiNapoli sits down with Kathy Day to respond to unanswered questions from PsychU’s Interacting with First Responders webinar. Their …

You must be logged-in to view this content.

2020 MHA Minority Mental Health: Facts & Stats

You must be logged-in to view this content.

2020 BIPOC Mental Health Month Toolkit

You must be logged-in to view this content.

U.N. Warns Of Global Mental Health Crisis Due To COVID-19 Pandemic

On May 13, 2020, the United Nations (UN) issued a warning that the coronavirus disease 2019 (COVID-19) pandemic could create …

You must be logged-in to view this content.

Role Of Pharmacogenetics Testing In Psychiatry

Joseph Goldberg, MD, and Lisa Goldstone, PharmD, MS, discuss the benefits and limitations of pharmacogenetics testing on current psychiatric practice …

You must be logged-in to view this content.

Could NMR-Spectroscopy Eventually Supplement Differential Diagnosis Decisions?

You must be logged-in to view this content.

Association of Cognition With Level Of Negative Symptomatology In First-Episode Psychosis

Schizophrenia is marked by considerable heterogeneity in clinical course and functional outcome. Two underlying reasons for this are differences in …

You must be logged-in to view this content.

CMS Continues Efforts To Expand Access To Telehealth Services

You must be logged-in to view this content.

Up To Half Of Americans Say Pandemic Has A ‘Serious Impact’ On Their Mental Health

You must be logged-in to view this content.

9% Of Long-Term Care Residents Receive Less Medication Than Needed Due To Inadequate Prescription Coverage

You must be logged-in to view this content.

About 10% Of Medicaid Beneficiaries With Behavioral Health Disorders Made Telehealth Visits In 2017

You must be logged-in to view this content.

Behavioral Health Provider Organizations Can Accept Donations Of Devices & Data Plans To Facilitate Telehealth During The COVID-19 Outbreak

You must be logged-in to view this content.

A Caregiver’s Perspective On Mental Health During Coronavirus Pandemic

As a caregiver, Kathy Day explains how her family member with schizophrenia is adjusting to life during the coronavirus pandemic. …

You must be logged-in to view this content.

Digital Endpoints & Medication Optimization

In this presentation Dr. Timothy Aungst, Associate Professor of Pharmacy at the Massachusetts College of Pharmacy and Health Sciences, discusses …

You must be logged-in to view this content.

The Nurse’s Role In Integrating & Improving Behavioral Care

You must be logged-in to view this content.

The Importance Of First Episode Psychosis Programs

You must be logged-in to view this content.

14% Of U.S. Households Have Accessed Mental Health Care To Address Problems Related To COVID-19 Pandemic

About 14% of households in the United States have had an immediate family member access mental health care to address …

You must be logged-in to view this content.

The Pharmacist’s Perspective During The Pandemic

In this presentation, Dr. Timothy Aungst, Associate Professor of Pharmacy Practice at the Massachusetts College of Pharmacy and Health Sciences, …

You must be logged-in to view this content.

National Quality Forum Endorses Four Behavioral Health Measures

You must be logged-in to view this content.

Two Distinct Subtypes Of Schizophrenia Discovered

You must be logged-in to view this content.

Are Interventions For Reducing Stigma Toward People With Severe Mental Illness Effective?

You must be logged-in to view this content.

Perspectives From The COVID-19 US Epicenter With Dr. René Kahn, Schizophrenia Section Advisor

You must be logged-in to view this content.

Impact Of Second-Generation Antipsychotics

Dr. Rajiv Tandon outlines treatment options for individuals with schizophrenia and the impact the illness can have on their daily functioning. …

You must be logged-in to view this content.

COVID-19 & Your Mental Health

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Download Resource
 
 
Provided with permission from Mental Health America, a PsychU Supporting Organization. To learn more about MHA, please visit their …

You must be logged-in to view this content.

Does Targeting Stigma Improve Quality Of Life For Individuals With Schizophrenia Or Major Depression?

You must be logged-in to view this content.

The Impact Of 2nd Generation Antipsychotic Side Effects On Functioning From Schizophrenia Patient Perspective: A Global Patient Centered Study

You must be logged-in to view this content.

Mental Health Education Roundtable: A Collaborative Discussion Among A Parent, Advocate & Educator

In July 2018, the state of New York became the first to require mental health instruction for all students, grades …

You must be logged-in to view this content.

Overcoming Stigma In Mental Health

You must be logged-in to view this content.

Fighting Loneliness In Social Distancing: A Conversation With Dr. Gaurava Agarwal

Dr. Gaurava Agarwal discusses the effect of social distancing, including loneliness, which he breaks down into three categories. He also …

You must be logged-in to view this content.

Joint Commission Releases New Enhanced Addiction Standards For Behavioral Health

You must be logged-in to view this content.

Use Of Telemedicine & Technology In The Treatment Of Mental Health During The COVID-19 Crisis

The COVID-19 crisis has increased the use of telemedicine to adapt to new social distancing guidelines. Transitioning to digital health …

You must be logged-in to view this content.

Balancing Act: Preventing Burnout For Health Care Professionals During The Coronavirus Pandemic & Times Of Crisis

You must be logged-in to view this content.

Meeting The Treatment Team Transitioning From Primary Care To Psychiatry

When primary care providers recommend mental health treatment, patients can feel apprehensive and flustered. Health care providers are asked questions …

You must be logged-in to view this content.

Nurses’ Role In Behavioral Health During The Crisis Of COVID-19

Anxiety, fear, and trauma can be rampant during times of natural disaster. Kimberly Lonergan, RN, MSN, interviews Tony Amberg to …

You must be logged-in to view this content.

Perspectives Of A Caregiver: Suicide & Safety Questions

This podcast highlights Kathy Day’s experience as a caregiver to her relative with mental illness. Ms. Day answers questions relating …

You must be logged-in to view this content.

Reentry Interventions Are More Successful When They Address Dynamic Risk Factors

Community reentry following incarceration is more likely to be successful if the reentry interventions address dynamic factors that affect the …

You must be logged-in to view this content.

Stigma’s Impact In Prison & After Release On Individuals With Mental Illness

You must be logged-in to view this content.

Cannabis: Potential Risks & Benefits In Mental Health

How might the use of marijuana or its components affect behavioral or physical health? During this webinar, Joseph McEvoy, MD, …

You must be logged-in to view this content.

The Impact Of COVID-19 On Mental Health Care: Perspectives From A Peer Specialist

Today’s podcast will focus on COVID-19’s impact on the work of a peer specialist in mental health care. It will …

You must be logged-in to view this content.

The COVID-19 Pandemic Effect On Advocacy: Perspective From Mental Health America

Mr. Paul Gionfriddo, President and CEO of Mental Health America (MHA), and Dr. Dennis Pabis, Senior Medical Science Liaison with …

You must be logged-in to view this content.

Disclosing To Others Fact Sheet

You must be logged-in to view this content.

Oregon Launches Family Connects Program To Improve Infant & Maternal Health

On February 13, 2020, the Oregon Health Authority (OHA) launched Family Connects to offer universal home visiting services to all …

You must be logged-in to view this content.

Sarpy County, Nebraska Planning New Jail With Space For Mental Health Resources

You must be logged-in to view this content.

Colorado Proposes Bill To Reimburse Behavioral Health Peer Support Professionals

You must be logged-in to view this content.

Impact Of Novel Coronavirus Pandemic On Mental Health

The COVID-19 pandemic isn’t affecting physical health only; it has an impact on mental health as well. In this webinar, Paul …

You must be logged-in to view this content.

Psychoneuroimmunology: Mood Disorders Part 2 In PNI Series

Drs. Rachel Self, Carolyn Tyler, and Heather Davidson provide an understanding of the immune system and neuroinflammation and their impact …

You must be logged-in to view this content.

Integrating Behavioral Care At A Nurse-Led Clinic

You must be logged-in to view this content.

Predicting Psychiatric Readmissions For Individuals Living With Borderline Personality Disorder

Borderline personality disorder (BPD) affects roughly 1% of the general population. Individuals living with this condition experience common symptomology with …

You must be logged-in to view this content.

App-Supported Smartphone Interventions for Mental Health Problems

You must be logged-in to view this content.

Northwestern University Recovery From Early Episode Psychosis Program (REPP)

Morris Goldman, MD, Stacy Prokopios, LCSW, and Lauren Walker, OTR/L, provide an overview of the Recovery from Early Episode Psychosis …

You must be logged-in to view this content.

Utilizing PsychU As A Resident

You must be logged-in to view this content.

Research Links Psychotic Disorders With Increased Age-Related Cognitive Impairment

You must be logged-in to view this content.

A Prescription For Pharmacist Intervention

Despite the well-known prevalence of mental health conditions, they are woefully undertreated. Consider this: About one in five Americans has …

You must be logged-in to view this content.

Psychotic Experiences & Psychiatric Comorbidity In The General Population Of Southeast London

You must be logged-in to view this content.

Factors Influencing Who Benefits From Cognitive Remediation Therapy

You must be logged-in to view this content.

Interacting With First Responders

You must be logged-in to view this content.

Interacting With First Responders

Approximately 15% of men and 30% of women jailed have a serious mental illness (SMI).1 Educated first responders can potentially …

You must be logged-in to view this content.

Painting A Broader Picture: Cognitive Remediation As A Nonpharmacologic Option For Treating Secondary Symptom Targets In Schizophrenia

You must be logged-in to view this content.

Types Of Mental Health Professionals Fact Sheet

You must be logged-in to view this content.

Depression Accounted For 44% Of 2018 Pennsylvania Mental Disorder Hospital Stays

In 2018, depression accounted for 44% of hospital stays for mental health issues in Pennsylvania. This was followed by schizophrenia …

You must be logged-in to view this content.

Social Cognition Treatment In Schizophrenia: Status & Opportunities

Individuals with schizophrenia struggle to interact with others due to impaired social cognition. Four capabilities in particular are compromised: 1.) …

You must be logged-in to view this content.

Cognitive Remediation: What Is the Impact of Peer Interaction?

You must be logged-in to view this content.

Medicaid Beneficiaries With Schizophrenia Had 50% To 92% Higher Health Care Utilization Rates

You must be logged-in to view this content.

Nearly One-Third Of Veterans With Schizophrenia Received No Antipsychotic Medication During The 12 Months Following Diagnosis

You must be logged-in to view this content.

Recovery After Initial Schizophrenic Episode – Early Treatment Program (RAISE-ETP) Interview With Dr. John Kane

John M. Kane provides commentary on the results of the Recovery After Initial Schizophrenic Episode – Early Treatment Program (RAISE-ETP) …

You must be logged-in to view this content.

Surviving Suicide: Interview with Laura Kaponer, Peer Support Specialist

You must be logged-in to view this content.

Meet The Treatment Team: Physician Assistant

You must be logged-in to view this content.

Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses

You must be logged-in to view this content.

PsychU Supporters: Cummings Institute – Doctor Of Behavioral Health Program

You must be logged-in to view this content.

Introduction To Marijuana

You must be logged-in to view this content.

Follow Up Q&A With Dr. Rowland – The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

PsychU Supporters: An Interview With Trinitas Regional Medical Center (TRMC)

We invite you to listen to our interview with James McCreath, Ph.D., LCSW, VP of Behavioral Health and Psychiatry at …

You must be logged-in to view this content.

PsychU Supporters: An Interview With Mental Health America (MHA)

Paul Gionfriddo, President and CEO of Mental Health America (MHA), sits down with PsychU to discuss the history and purpose …

You must be logged-in to view this content.

Follow Up Q&A With Dr. Murrough – The Role Of Glutamate In Mood Disorders & Schizophrenia

During this question and answer session, Dr. James Murrough responds to unanswered questions from the PsychU webinar, “The Role of …

You must be logged-in to view this content.

Long-Acting Injectable Antipsychotics & How To Give An Intramuscular Injection

You must be logged-in to view this content.

Cognitive Function & Neuroprotection In Schizophrenia

Schizophrenia has a worldwide prevalence of approximately 1%.1 Individuals living with the disease often experience neurocognitive deficits, as well as …

You must be logged-in to view this content.

Recovery After Initial Schizophrenic Episode – Early Treatment Program (RAISE-ETP)

You must be logged-in to view this content.

The Neurobiology Of Endocannabinoids

You must be logged-in to view this content.

The Neurobiology Of Opioids

You must be logged-in to view this content.

The Interplay Between Sleep & Physical Activity For Patients Living With Schizophrenia

You must be logged-in to view this content.

Half Of People With Early Psychosis Symptoms May Not Have Schizophrenia

You must be logged-in to view this content.

Is It Suicide Risk Or Risk Of Psychiatric Illness? Re-Examining The Nature Of Sex-Specific Suicide Risk Factors

You must be logged-in to view this content.

State Of The Science 2019: Advances In Understanding & Treating Schizophrenia

You must be logged-in to view this content.

The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

Webinar Summary – The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

California’s Ventura County Seeks Services For Early Detection, Intervention & Prevention Of Psychosis

You must be logged-in to view this content.

RASP: A Self-Report Tool For Relapse Risk In Patients Living With Schizophrenia

You must be logged-in to view this content.

Relapse Risk Assessment In Patients With Schizophrenia (RASP)

You must be logged-in to view this content.

Long-Acting Injectable Antipsychotic Screening, Utilization, & Effects: The RUHS Medical Center Case Study

Riverside University Health System (RUHS) is an academic, tertiary care medical center and county safety-net facility operating a 77 bed …

You must be logged-in to view this content.

Understanding Psychiatric Diagnoses Using Mnemonics: Schizophrenia

You must be logged-in to view this content.

Webinar Summary: Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members …

You must be logged-in to view this content.

Hospital Utilization Following Antipsychotic Medication Dose Reduction: Balancing Side Effect Management With Risk Of Relapse

You must be logged-in to view this content.

FDA Authorizes 23andMe Direct-To-Consumer Pharmacogenetic Reports

You must be logged-in to view this content.

Webinar Summary – Beyond Molecular Biomarkers In Psychiatry: Advances In The Digital Age

You must be logged-in to view this content.

Pharmacological Treatment Factors Associated With Type 2 Diabetes In Patients With Schizophrenia

You must be logged-in to view this content.

Webinar Summary – Humanizing Bipolar Disorder: David’s Story Of Hope, Recovery, & Wellness

You must be logged-in to view this content.

Polypharmacy Therapy For Schizophrenia Increases Risk For Type 2 Diabetes

You must be logged-in to view this content.

The Prevalence Of Antipsychotic Polypharmacy Decreased 4.6% Between 2008 & 2014

You must be logged-in to view this content.

Machine Learning Helps Predict Instance & Treatment Outcomes Of Schizophrenia

You must be logged-in to view this content.

Webinar Summary – Can We Improve Functioning In Our Patients With Schizophrenia?: Side Effect Burden & Recovery Approach To Informed Decision Making

You must be logged-in to view this content.

Can We Improve Functioning In Our Patients With Schizophrenia?

Clinicians are tasked daily with making informed decisions regarding patients. During this webinar, Greg Mattingly, MD, Medical Director at St. …

You must be logged-in to view this content.

Webinar Summary – The Aftermath Of Suicide: What Can Be Done & How Should We Talk About It?

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, …

You must be logged-in to view this content.

Emergency Use 60% Higher Among Consumers With Schizophrenia & Not Taking Antipsychotics As Directed

North Carolina Medicaid beneficiaries diagnosed with schizophrenia who failed to take antipsychotic medications as directed had 60% more emergency department …

You must be logged-in to view this content.

Over 10% Of Ontario Suicide Deaths Are Among People With Schizophrenia

About 11.7% of the 5,650 people who died of suicide in Ontario, Canada from January 2008 through December 2012 had …

You must be logged-in to view this content.

Introducing RASP: Relapse Assessment In Schizophrenia Patients

Nearly 3.4 million adults, or 1.1% of the U.S. population, have a diagnosis of schizophrenia.1,2 As a chronic, relapsing3 condition, those who …

You must be logged-in to view this content.

Webinar Summary – Introducing RASP: Relapse Assessment In Schizophrenia Patients

You must be logged-in to view this content.

Early Intervention Services Have Superior Outcomes For Early-Phase Psychosis

People with early-phase psychosis who received a set of services considered “early intervention services” (EIS) had more symptom improvement, a …

You must be logged-in to view this content.

How Media & Movies Shape Our Perception Of Serious Mental Illness

During this webinar, experts Georgia Stevens, PhD, APRN, PMHCNS-BC, Psychiatric Nurse & Director of Partners in Aging & Long-Term Caregiving, …

You must be logged-in to view this content.

It’s A Small World: Similarities & Differences In Health Behaviors & Life Satisfaction Among Individuals With Mental Illness From Four Countries

You must be logged-in to view this content.

Where Are We Now? Recent Findings Push Research Beyond Initial Results From The CATIE Study

You must be logged-in to view this content.

Reducing Relapse In Schizophrenia Starts With Predicting Relapse

You must be logged-in to view this content.

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, & Therapy

You must be logged-in to view this content.

Five Years Of Specialised Early Intervention Versus Two Years Of Specialised Early Intervention Followed By Three Years Of Standard Treatment For Patients With A First Episode Psychosis: Randomised, Superiority, Parallel Group Trial In Denmark (OPUS II)

You must be logged-in to view this content.

The State Of Mental Health In America In 2018: An Interview With Paul Gionfriddo

Mental Health America (MHA), a leading nationwide nonprofit organization dedicated to promoting the mental wellness of all Americans, has released …

You must be logged-in to view this content.

Long-Acting Injectable Adherence & Sociodemographic Characteristics Of Use

In this interview, James McCreath, PhD, Vice President of Psychiatry & Behavioral Health at the Trinitas Regional Medical Center, discusses …

You must be logged-in to view this content.

Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE): Summary Results From Phase I

You must be logged-in to view this content.

Increasing Serum G72 Protein Levels In Patients With Schizophrenia: A Potential Candidate Biomarker

You must be logged-in to view this content.

Webinar Summary – Caring For The Patient With Schizophrenia: Nursing, Pharmacy, & Social Work Perspectives

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members …

You must be logged-in to view this content.

Caring For The Patient With Schizophrenia: Nursing, Pharmacy, & Social Work Perspectives

Given the complexity of schizophrenia and suboptimal treatment outcomes, it is important that a multidisciplinary approach be considered when caring …

You must be logged-in to view this content.

Stressors & Psychological Distress Among Informal Caregivers Of Relatives With Mental Illness

You must be logged-in to view this content.

23% Of Hospital Admissions For Psychosis Resulted In Readmission Within 30 Days

You must be logged-in to view this content.

Training Patients With Schizophrenia To Share Decisions With Their Psychiatrist: A Randomized-Controlled Trial

Key Messages

Many patients with schizophrenia would like to participate in shared decision-making (SDM) with their health care providers. In observed …

You must be logged-in to view this content.

Most States Fail To Provide Adequate Evidence-Based Treatment For Offenders With SMI

You must be logged-in to view this content.

Danish Consumers With Diabetes & Schizophrenia 10% Less Likely To Receive High-Quality Diabetes Care

You must be logged-in to view this content.

Webinar Summary – Tools To Assess & Address Medication Adherence In Patients With Serious Mental Illness

You must be logged-in to view this content.

Blood Test Detects Physiological Markers To Differentiate Depression From Schizophrenia

You must be logged-in to view this content.

Treating The Synapse In Major Psychiatric Disorders: The Role of Postsynaptic Density Network In Dopamine-Glutamate Interplay & Psychopharmacologic Drugs Molecular Actions

You must be logged-in to view this content.

Webinar Summary – Early Intervention In Schizophrenia: Targeting Metabolic Dysfunction

You must be logged-in to view this content.

Early Intervention In Schizophrenia: Targeting Metabolic Dysfunction

Increasingly, schizophrenia is considered a medical psychiatric disease. There is evidence that metabolic changes occur within the first episode of …

You must be logged-in to view this content.

Webinar Summary – Pharmacogenomics & Personalized Medicine: Where Are We Now & Where Are We Going?

You must be logged-in to view this content.

20-Minute Screening Evaluates Cognitive Impairment Due To Schizophrenia

You must be logged-in to view this content.

Families & Medication Use & Adherence Among Latinos With Schizophrenia

You must be logged-in to view this content.

Reduced Insulin-Receptor Mediated Modulation Of Striatal Dopamine Release By Basal Insulin As A Possible Contributing Factor To Hyperdomaminergia In Schizophrenia

You must be logged-in to view this content.

Association Of Social Support & Quality Of Life Among People With Schizophrenia Receiving Community Psychiatric Service: A Cross-Sectional Study

You must be logged-in to view this content.

High-Intensity Transcranial Magnetic Stimulation Reduces Severity Of Auditory Hallucinations

You must be logged-in to view this content.

University Of Alberta & IBM Testing Artificial Intelligence To Diagnose Schizophrenia

You must be logged-in to view this content.

Why Schizophrenia Remains ‘Top Of Mind’ At Health Plans

You must be logged-in to view this content.

Data Show Criminal Justice Reform In California Has Not Benefited Prisoners With Mental Illness

You must be logged-in to view this content.

Self-Perceived Cognitive Deficits & Their Relationship With Internalized Stigma & Quality Of Life In Patients With Schizophrenia

You must be logged-in to view this content.

Ten-Year Outcomes Of First-Episode Psychoses In The MRC ÆSOP-10 Study

You must be logged-in to view this content.

Schizophrenia: The Role Of Sleep & Circadian Rhythms In Regulating Dopamine & Psychosis

You must be logged-in to view this content.

Coping Strategies & Self-Stigma In Patients With Schizophrenia-Spectrum Disorders

You must be logged-in to view this content.

Anxiety Symptoms In A Major Mood & Schizophrenia Spectrum Disorders

You must be logged-in to view this content.

Training To Enhance Psychiatrist Communication With Patients With Psychosis (TEMPO): Cluster Randomised Controlled Trial

You must be logged-in to view this content.

Long-Term Suicide Rate After Psychiatric Discharge Averages 484 Per 100,000 Person-Years

Long-term suicide rates after discharge from a psychiatric facility were estimated at a 10-year average of 484 suicides per 100,000 …

You must be logged-in to view this content.

Adherence To Antipsychotics Associated With Lower Psychiatric Hospitalization Rates & Expenditures

Adherence to antipsychotic therapy among Medicare Part D enrollees with schizophrenia is associated with a lower probability of psychiatric hospitalization …

You must be logged-in to view this content.

Study Shows Involving Individuals With Mental Illness In Managing Their Health May Prevent Emergency Room Visits

You must be logged-in to view this content.

Health Technology Intervention After Hospitalization For Schizophrenia: Service Utilization & User Satisfaction

You must be logged-in to view this content.

Clinical Application Of Psychopharmacology Of Schizophrenia – John Miller, MD

This interview with John Miller, MD is part 3 of the 3-part module series on Schizophrenia, from the Psychopharmacology Collection.

You must be logged-in to view this content.

Mental Health America’s National Peer Support Specialist Certification

You must be logged-in to view this content.

Recovery In Schizophrenia: What Consumers Know & Do Not Know

You must be logged-in to view this content.

No Supportive Evidence For The Use Of Multiple Long-Acting Antipsychotic Therapies In Patients With Schizophrenia

You must be logged-in to view this content.

A Tool To Predict Risk Of Violence In Individuals With Schizophrenia Spectrum Or Bipolar Disorder

You must be logged-in to view this content.

Cerebral White Matter Structure Is Associated With DSM-5 Schizophrenia Symptom Dimensions

You must be logged-in to view this content.

Neuroinflammation & White Matter Pathology In Schizophrenia: Systematic Review

You must be logged-in to view this content.

Neuroinflammation & Psychiatric Illness

You must be logged-in to view this content.

Genetics Of Schizophrenia & Smoking: An Approach To Studying Their Comorbidity Based On Epidemiological Findings

You must be logged-in to view this content.

Genetic Correlates Of Medical Comorbidity Associated With Schizophrenia & Treatment With Antipsychotics

You must be logged-in to view this content.

Stigma & Discrimination Experienced By People Living With Severe & Persistent Mental Illness In Assertive Community Treatment Settings

You must be logged-in to view this content.

Dopamine Theory & Treatment Considerations In Schizophrenia

This video is part 1 in a series focusing on the psychopharmacology of schizophrenia. This video provides an overview of …

You must be logged-in to view this content.

Pathophysiology & Evolving Theories In Schizophrenia

This presentation is part 2 in a series focusing on the psychopharmacology of schizophrenia. This presentation reviews regions of the …

You must be logged-in to view this content.

Webinar Summary – Looking Beyond Mood & Psychosis: A Focus On Neurocognition

You must be logged-in to view this content.

Looking Beyond Mood & Psychosis: A Focus On Neurocognition

Historically, cognitive impairment was considered an artifact of patients’ symptoms, attention, or motivation problems, and as such, was an underappreciated …

You must be logged-in to view this content.

Are Pets A “Hidden Resource” For Self-Management Of Long-Term Mental Illness?

You must be logged-in to view this content.

First-Episode Psychosis Intervention Did Not Reduce Receipt Of Social Security Disability Benefits More Than Usual Care

You must be logged-in to view this content.

New Neuro-Pathway Affecting Schizophrenia Discovered

You must be logged-in to view this content.

Virtual Forum Summary: Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry

You must be logged-in to view this content.

Cognitive Impairment In Schizophrenia: Cognitive Remediation & The Potential Role Of Digital Technology

You must be logged-in to view this content.

Role Of The Caregiver In The Overall Treatment Plan

You must be logged-in to view this content.

Mental Health Awareness Month 2017 – Henry A. Nasrallah, MD

You must be logged-in to view this content.

Negative Symptoms & Functioning During The First Year After A Recent Onset Of Schizophrenia & Eight Years Later

You must be logged-in to view this content.

Introduction To Schizophrenia

You must be logged-in to view this content.

Finding Mental Health That Fits Your Cultural Background

You must be logged-in to view this content.

Dual Diagnosis Fact Sheet

You must be logged-in to view this content.

Schizophrenia Fact Sheet

You must be logged-in to view this content.

Sleep Disorders Fact Sheet

You must be logged-in to view this content.

Student Guide To Mental Health: Getting The Right Start

You must be logged-in to view this content.

Psychosis Fact Sheet

You must be logged-in to view this content.

Mental Health Facts In America

You must be logged-in to view this content.

Multicultural Mental Health Facts

You must be logged-in to view this content.

Mental Health: Know The Warning Signs

You must be logged-in to view this content.

Taking Charge Of Your Mental Health

You must be logged-in to view this content.

What Is Mental Health Parity?

You must be logged-in to view this content.

Mental Health: Maintaining A Healthy Lifestyle

You must be logged-in to view this content.

Mental Health: Managing Stress

You must be logged-in to view this content.

Student Guide To Mental Health: How To Help A Friend

You must be logged-in to view this content.

Mental Health: How To Find Help

You must be logged-in to view this content.

Insulin: The Overlooked Neuromodulator

You must be logged-in to view this content.

Stop Thinking Stupid Thoughts

You must be logged-in to view this content.

Think Ahead

You must be logged-in to view this content.

What’s Underneath

You must be logged-in to view this content.

Cognitive Behavioral Therapy For Psychosis Can Improve Brain Function In People With Schizophrenia

You must be logged-in to view this content.

Reaching For Recovery: Schizophrenia

You must be logged-in to view this content.

Working With The Treatment Team: Schizophrenia

You must be logged-in to view this content.

Connecting With Your Loved One Help Sheet: Schizophrenia

You must be logged-in to view this content.

Caregivers & The Right To Help: Schizophrenia

You must be logged-in to view this content.

Rutgers Opens Early Psychosis Intervention Clinic For Young Adults

You must be logged-in to view this content.

There’s A Person In There

You must be logged-in to view this content.

Making Yourself A Priority

You must be logged-in to view this content.

My Experience On How Medication & Therapy Work Together

You must be logged-in to view this content.

Accept Help When It’s Offered

You must be logged-in to view this content.

In The Workplace

You must be logged-in to view this content.

Mental Health Month 2016 Toolkit

You must be logged-in to view this content.

Webinar Summary – Impending Signs of Psychosis: Focus on Caregiver & Patient Engagement

You must be logged-in to view this content.

Impending Signs Of Psychosis: Focus On Caregiver & Patient Engagement

The majority of individuals who experience psychosis in schizophrenia will eventually relapse, making an individual’s ability to identify early warning …

You must be logged-in to view this content.

Webinar Summary – Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

You must be logged-in to view this content.

Advanced Receptor Psychopharmacology

This video is part 3 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This …

You must be logged-in to view this content.

Advanced Neurotransmitters & Neuroglia

This video is part 2 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This …

You must be logged-in to view this content.

Follow Up Q&A – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

During this question and answer session, Henry A. Nasrallah, MD and Roger Sommi, PharmD, BCPP, FCCP respond to unanswered questions …

You must be logged-in to view this content.

Webinar Summary – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members …

You must be logged-in to view this content.

Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

While treating to remission is the goal in schizophrenia, it remains a target not achieved for many patients. In this …

You must be logged-in to view this content.

Psychiatric Emergency & Crisis

You must be logged-in to view this content.

First-Episode Psychosis Incidence Estimated At 0.86 Per 1,000 Population Between 15-29 Years Old

You must be logged-in to view this content.

Characteristic Distributions Of Regional Cerebral Blood Flow Changes In Major Depressive Disorder Patients: A Pseudo-Continuous Arterial Spin Labeling (pCASL) Study

You must be logged-in to view this content.

Inflammation In Neurological & Psychiatric Diseases

You must be logged-in to view this content.

Total & Differential White Blood Cells Counts, High-Sensitivity C-Reactive Protein, & Cardiovascular Risk In Non-Affective Psychoses

You must be logged-in to view this content.

Auditory Dysfunction In Schizophrenia: Integrating Clinical & Basic Features

You must be logged-in to view this content.

The Potential Of Immune Biomarkers To Advance Personalized Medicine Approaches For Schizophrenia

You must be logged-in to view this content.

Pharmacokinetics: The Basics

You must be logged-in to view this content.

An Overview Of Treatment Options & Cost For Schizophrenia

You must be logged-in to view this content.

National Study Shows Rate Of Health Care Utilization Growth Slowed During 2003-2014; Adults With Serious Psychological Distress Are High Utilizers Of Services

You must be logged-in to view this content.

Effectively Measuring The Functional Capacity Of Individuals With Serious Mental Illness

You must be logged-in to view this content.

Lifestyle Interventions Get The Medicare Greenlight

You must be logged-in to view this content.

17% Of U.S. Adults Used Psychiatric Drugs In 2013

You must be logged-in to view this content.

How Does Genetic Counseling Impact Individuals With Serious Mental Illness?

You must be logged-in to view this content.

Detecting & Managing Cardiovascular Disease For Individuals With Serious Mental Illness

You must be logged-in to view this content.

Webinar Summary – Meeting The Challenges In Caring For Patients With Schizophrenia: Roles Of The Pharmacist

You must be logged-in to view this content.

Meeting The Challenges In Caring For Patients With Schizophrenia: Roles Of The Pharmacist

Addressing the challenges of caring for patients with schizophrenia in terms of treatment, recovery, and remission requires a coordinated effort …

You must be logged-in to view this content.

Half Of American Adults With Mental Health Problems Are Untreated

You must be logged-in to view this content.

Researchers Developing Universal Predictive Measure For Suicidality

Health care professionals understand that early intervention of serious mental illness can prevent an individual from suffering disabilities, hospitalizations, incarceration, …

You must be logged-in to view this content.

Measuring Personal Recovery Of People With Serious Mental Illness Using The Maryland Assessment Of Recovery Scale

You must be logged-in to view this content.

Ex-Offenders’ Violent Recidivism Reduced By Taking Psychotropic Medications

You must be logged-in to view this content.

CBT For People With Ultra-High Risk Of Psychosis Lowers Incidence By 44%

You must be logged-in to view this content.

Webinar Summary – Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

You must be logged-in to view this content.

Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

While past decades saw a boom in the development of innovative new treatments in the field of psychiatry, the pace …

You must be logged-in to view this content.

A Comparison Of Stigmatizing Attitudes Toward Persons With Schizophrenia In Four Stakeholder Groups: Perceived Likelihood Of Violence & Desire For Social Distance

You must be logged-in to view this content.

A Systematic Review Of Factors Influencing Adherence To Antipsychotic Medication In Schizophrenia-Spectrum Disorders

You must be logged-in to view this content.

A Splitting Brain: Imbalanced Neural Networks In Schizophrenia

You must be logged-in to view this content.

A Molecular Pathway Analysis Informs The Genetic Background At Risk For Schizophrenia

You must be logged-in to view this content.

An Individualized Risk Calculator For Research In Prodromal Psychosis

You must be logged-in to view this content.

Unraveling The Mechanisms Responsible For The Comorbidity Between Metabolic Syndrome & Mental Health Disorders

You must be logged-in to view this content.

Rethinking The Genetic Basis For Comorbidity Of Schizophrenia & Type 2 Diabetes

You must be logged-in to view this content.

How Prevalent Are Anxiety Disorders In Schizophrenia? A Meta-Analysis & Critical Review On A Significant Association

You must be logged-in to view this content.

Adding CBT To Treatment Decreases Likelihood Of First Episode Psychosis In High-Risk Consumers

You must be logged-in to view this content.

Anxiety Comorbidity in Schizophrenia

You must be logged-in to view this content.

About 40% Of Inmates In San Francisco County Jail Need Behavioral Health Services; 15% Are Treated For Serious Mental Illness

You must be logged-in to view this content.

Payer Considerations In Managing Schizophrenia Relapse Reduction: Schizophrenia Overview

You must be logged-in to view this content.

Case Studies In Schizophrenia: Long-Acting Injectables (LAIs) As A Treatment Option

You must be logged-in to view this content.

Frameworks in Health & Quality: Schizophrenia Relapse Reduction Program

You must be logged-in to view this content.

A Guide For Caregivers: Understanding Schizophrenia Relapse

You must be logged-in to view this content.

Wellness & Recovery Workbook

This tool is designed to help patients recognize and manage symptoms of schizophrenia. Patients can use it as practical support …

You must be logged-in to view this content.

Preparing To Leave The Hospital

You must be logged-in to view this content.

A Guide For Patients: Managing Schizophrenia

You must be logged-in to view this content.

A Guide For Patients: Living With Schizophrenia

You must be logged-in to view this content.

A Guide For Patients: Understanding How Your Medicine Can Help

You must be logged-in to view this content.

A Guide for Patients: Understanding Schizophrenia Relapse

You must be logged-in to view this content.

Schizophrenia & The Role Of The Pharmacist

You must be logged-in to view this content.

Treatment Adherence In Schizophrenia: Engagement Strategies For Health Care Providers, Case Managers, & Advocates

You must be logged-in to view this content.

Case Manager: Reducing Risk Of Relapse In People With Schizophrenia

You must be logged-in to view this content.

Medication Reconciliation For People With Schizophrenia

You must be logged-in to view this content.

Medication Options For People With Schizophrenia

You must be logged-in to view this content.

Schizophrenia & Relapse: Key Issues & Concerns For Hospital Team Members

You must be logged-in to view this content.

Schizophrenia & Relapse: Key Issues & Concerns For Health Care Providers

You must be logged-in to view this content.

Case Study In Schizophrenia: Long-Acting Injectables As A Treatment Option—Jenny

You must be logged-in to view this content.

Case Study In Schizophrenia: Long-Acting Injectables As A Treatment Option—Anton

You must be logged-in to view this content.

Addressing Relapse & Readmissions In Schizophrenia

You must be logged-in to view this content.

HEDIS Quality Improvement Project: Measurement & Intervention Development

This document  outlines potential opportunities for health care quality improvement that may be derived from HEDIS®.  Two particular HEDIS® measures …

You must be logged-in to view this content.

Schizophrenia & Relapse: Key Issues & Concerns For Payers

You must be logged-in to view this content.

Cómo Prepararse Para Dejar El Hospital – Versión Española

You must be logged-in to view this content.

Guía Para Pacientes: Cómo Controlar La Esquizofrenia – Versión Española

You must be logged-in to view this content.

Guía Para Pacientes: Vivir Con Esquizofrenia – Versión Española

You must be logged-in to view this content.

Cuaderno De Trabajo Sobre El Bienestar Y La Recuperación – Versión Española

You must be logged-in to view this content.

Guía Para Cuidadores: Comprender Qué Es Una Recaída En La Esquizofrenia- Versión Española

You must be logged-in to view this content.

Guía Para Pacientes: Comprender Cómo Los Medicamentos Pueden Ayudar – Versión Española

You must be logged-in to view this content.

Guía Para Pacientes: Comprender Qué Es Una Recaída En La Esquizofrenia – Versión Española

You must be logged-in to view this content.

Phenotypically Distinct Subtypes of Psychosis Accompany Novel or Rare Variants in Four Different Signaling Genes

You must be logged-in to view this content.

Brain Scans Of Individuals With Schizophrenia Show Regeneration Of Damaged Brain Matter Over Time

You must be logged-in to view this content.

Risk Factors Associated With Psychiatric Readmission

You must be logged-in to view this content.

Children Living In Urban Areas Have Higher Rates Of Psychotic Symptoms

You must be logged-in to view this content.

New Maine Medicaid Policy Limits Most Mental Health Community Support Services To People With Schizophrenia Or Schizoaffective Disorder

You must be logged-in to view this content.

Follow Up Q&A – Managing Metabolic Wellness In The Mentally Ill: Perspectives From Both A Primary Care Provider (PCP) & A Psychiatrist

You must be logged-in to view this content.

Webinar Summary – Managing Metabolic Wellness In The Mentally Ill: Perspectives From A Primary Care Physician & A Psychiatrist

You must be logged-in to view this content.

Managing Metabolic Wellness In The Mentally Ill: Perspectives From Both A Primary Care Physician (PCP) & A Psychiatrist

Metabolic wellness is an extremely important consideration in treating patients with schizophrenia, who have an increased incidence of cardiometabolic risk …

You must be logged-in to view this content.

People Diagnosed With Schizophrenia Use Digital Technology At Same Rate As General Population

You must be logged-in to view this content.

Readmission Patterns & Effectiveness of Transitional Care Among Medicaid Patients With Schizophrenia & Medical Comorbidity

You must be logged-in to view this content.

Four New Genetic Diseases Defined Within Schizophrenia

You must be logged-in to view this content.

What Are Residual Symptoms in Schizophrenia Spectrum Disorder? Clinical Description & 1-Year Persistence Within a Naturalistic Trial

You must be logged-in to view this content.

Webinar Summary – Understanding & Addressing Medication Adherence In Psychiatry

You must be logged-in to view this content.

Interview with Lurline Nieto | Psychiatric Nurse Practitioner

You must be logged-in to view this content.

Metabolic Syndrome In Bipolar Disorder & Schizophrenia: Dietary & Lifestyle Factors Compared To The General Population

You must be logged-in to view this content.

Defining Therapeutic Benefit For People With Schizophrenia: Focus On Negative Symptoms

You must be logged-in to view this content.

First Outpatient Follow-up After Psychiatric Hospitalization: Does One Size Fit All?

You must be logged-in to view this content.

Schizophrenia—A Medical Psychiatric Syndrome

You must be logged-in to view this content.

Webinar Summary – Recovery In The Community: Can We Do Better?

You must be logged-in to view this content.

Recovery In The Community: Can We Do Better?

A goal for all patients with mental illness should be symptom reduction and optimal psychosocial functioning. In this webinar, experienced …

You must be logged-in to view this content.

A Longitudinal Examination Of The Moderating Effects Of Symptoms On The Relationship Between Functional Competence & Real World Functional Performance In Schizophrenia

You must be logged-in to view this content.

Co-Occurring Psychotic & Addictive Disorders: Neurobiology & Diagnosis

You must be logged-in to view this content.

Approaches To Improve Adherence To Pharmacotherapy In Patients With Schizophrenia

You must be logged-in to view this content.

Webinar Summary – NCQA© HEDIS® Measures & Mental Health: The Current Landscape & Future Developments

You must be logged-in to view this content.

Webinar Summary – Suboptimal Response in Psychotic & Mood Disorders: Causes, Consequences, & Management Strategies

You must be logged-in to view this content.

Suboptimal Response In Psychotic & Mood Disorders: Causes, Consequences, & Management Strategies

Suboptimal response is a common challenge and can lead to negative consequences for patients diagnosed with serious mental illness. In …

You must be logged-in to view this content.

An Updated Review On Burden On Caregivers Of Schizophrenia Patients

You must be logged-in to view this content.

Psychiatric Readmissions In A Community-Based Sample Of Patients With Mental Disorders

You must be logged-in to view this content.

56% Of Medicaid Beneficiaries With A Psychiatric Diagnosis Had Claims For Psychotropic Medications

You must be logged-in to view this content.

Psychiatric 30-Day Readmission Rates Were 9% For Mood Disorders; 15% For Schizophrenia

You must be logged-in to view this content.

Webinar Summary – A Foundational Approach To The Treatment Of Schizophrenia

You must be logged-in to view this content.

A Foundational Approach To The Treatment Of Schizophrenia

Schizophrenia is a chronic and devastating illness, affecting more than 21 million people globally. In this webinar, experienced psychiatrists Noel …

You must be logged-in to view this content.

Perspectives In Schizophrenia: Proposed Disease Pathophysiology & Potential Treatment Implications

You must be logged-in to view this content.

‘Antipsychotics Are Alike, But Their Similarities Are Different’

You must be logged-in to view this content.

Use Of Biotypes Offers More Precise Diagnoses Of SMI Than The DSM

You must be logged-in to view this content.

Webinar Summary – A Collaborative Approach To Care Coordination For Patients With Schizophrenia: Perspectives From Nursing & Social Work

You must be logged-in to view this content.

A Collaborative Approach To Care Coordination For Patients With Schizophrenia: Perspectives From Nursing & Social Work

Many patients with schizophrenia fail to transition from inpatient settings to community mental health settings. In this webinar, Brooke Kempf …

You must be logged-in to view this content.

Detection & Characteristics Of Individuals With A Very Long Duration Of Untreated Psychosis In An Early Intervention For Psychosis Service

You must be logged-in to view this content.

Clinical Correlates Of Initial Treatment Disengagement In First-Episode Psychosis

You must be logged-in to view this content.

Who Is Paying The Price? Loss Of Health Insurance Coverage Early In Psychosis

You must be logged-in to view this content.

Is Early Intervention For Psychosis Feasible & Effective?

You must be logged-in to view this content.

Inflammation & The Two-Hit Hypothesis Of Schizophrenia

You must be logged-in to view this content.

The Cytokine Model of Schizophrenia: Emerging Therapeutic Strategies

You must be logged-in to view this content.

Comprehensive Versus Usual Community Care For First-Episode Psychosis: 2-Year Outcomes From The NIMH RAISE Early Treatment Program

You must be logged-in to view this content.

Pathways To (Specialized) Care: Patient Costs & Contacts En Route To A First-Episode Psychosis Clinic

You must be logged-in to view this content.

The Challenges Of Treating Patients With Schizophrenia

You must be logged-in to view this content.

Severity Of Psychosis Syndrome & Change Of Metabolic Abnormality In Chronic Schizophrenia Patients: Severe Negative Syndrome May Be Related To A Distinct Lipid Pathophysiology

You must be logged-in to view this content.

Early Intervention In Psychosis

You must be logged-in to view this content.

Mortality Rates Among Adult Medicaid Beneficiaries With Schizophrenia 3.5 Times Higher Than General Population

You must be logged-in to view this content.

Smartphone App Found Feasible For Managing Schizophrenia

You must be logged-in to view this content.

Comprehensive, Team-Based Treatment For First Episode Psychosis Linked To Better Outcomes Than Traditional Community-Based Treatment

You must be logged-in to view this content.

Do People With Serious Mental Illness Receive Quality Medical Care?

You must be logged-in to view this content.

Violent Reoffenses More Likely In Ex-Offenders With Psychiatric Diagnoses

You must be logged-in to view this content.

Men With Schizophrenia Make Twice As Many Emergency Department Visits As Women With Schizophrenia

You must be logged-in to view this content.

Individuals With Serious Mental Illness (SMI) & Type 2 Diabetes: Clinical Correlates Of Diabetes Control

You must be logged-in to view this content.

Investigating White Matter Abnormalities In Brains Of People With Schizophrenia

You must be logged-in to view this content.

Rearrest Rates Drop From 80% To 28% For Mental Health Court Participants

You must be logged-in to view this content.

Brief Adherence Ratings Scale (BARS)

You must be logged-in to view this content.

Early Intervention In Psychosis: Benefits, Barriers, & Best Practices

You must be logged-in to view this content.

Older Adults Prescribed Psychotropics At Twice The Rate Of Younger Adults, But See Psychiatrists Less

You must be logged-in to view this content.

The Neurobiology Of Relapse In Schizophrenia

You must be logged-in to view this content.

Developing A Cognitive Training Strategy For First-Episode Schizophrenia: Integrating Bottom-Up & Top-Down Approaches

You must be logged-in to view this content.

Dopamine Supersensitivity Psychosis (DSP): Is It A Factor in Treatment-Resistant Schizophrenia?

You must be logged-in to view this content.

Co-Morbidity Of Alcohol Use Disorders & Schizophrenia In The Developing World

You must be logged-in to view this content.

The Role Of Pro-Inflammatory Cytokines In The Neuroinflammation & Neurogenesis Of Schizophrenia

You must be logged-in to view this content.

Half Medicaid Population With SMI Do Not Receive Continuous Supply Of Psych Meds

You must be logged-in to view this content.

Best Practice: Clinical Practice Guideline: Optum Schizophrenia Coverage Determination Guidelines

You must be logged-in to view this content.

The Current State Of Schizophrenia From Rebecca Roma, MD, MBA

You must be logged-in to view this content.

The Current State Of Schizophrenia From Peter J. Weiden, MD

You must be logged-in to view this content.

Webinar Summary – Distinguishing Sedation From Efficacy In Antipsychotic Treatment

You must be logged-in to view this content.

Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Agitation is frequently seen in patients with schizophrenia. When treating acute agitation in these patients, minimizing sedation should be a …

You must be logged-in to view this content.

Managing The Patient With Schizophrenia: Striking A Balance Between Symptom Control & Tolerability

You must be logged-in to view this content.

Early Intervention For Psychotic Disorders In A Community Mental Health Center

You must be logged-in to view this content.

Reducing Duration Of Untreated Psychosis: Care Pathways To Early Intervention In Psychosis Services

You must be logged-in to view this content.

An Overview Of The Brief Adherence Rating Scale (BARS)

You must be logged-in to view this content.

An Innovative Method Of Teaching Psychopharmacology To Psychiatry Residents

You must be logged-in to view this content.

Long-Term Follow-Up Of The TIPS Early Detection In Psychosis Study: Effects On 10-Year Outcome

You must be logged-in to view this content.

Webinar Summary – Treating The Patient With Schizophrenia: Striking A Balance Between Symptom Control & Tolerability

You must be logged-in to view this content.

Treating The Patient With Schizophrenia: Striking A Balance Between Symptom Control & Tolerability

Psychosis is ranked as one of the top three most disabling conditions worldwide. Quality of life is commonly impaired in …

You must be logged-in to view this content.

Disengagement From Mental Health Treatment Among Individuals With Schizophrenia & Strategies For Facilitating Connections To Care: A Review Of The Literature

You must be logged-in to view this content.

Impact Of Early Intervention Services On Duration Of Untreated Psychosis: Data From The National EDEN Prospective Cohort Study

You must be logged-in to view this content.

People With Mental Health Issues Have Higher Than Average Mortality Rate, With 14.3% Of Deaths Worldwide Attributable To Mental Health Disorders

You must be logged-in to view this content.

New Neuroimaging Research May Change The Way Mental Illness Is Diagnosed

You must be logged-in to view this content.

Youth With Certain Genetic Disorders Are Likely To Show Cognitive Decline Before Onset Of Psychosis

You must be logged-in to view this content.

UK Releases New Quality Of Care Standards For Adults Diagnosed With Psychosis Or Schizophrenia

You must be logged-in to view this content.

Global Burden Of Disease Attributable To Mental & Substance Use Disorders: Findings From The Global Burden Of Disease Study 2010

You must be logged-in to view this content.

Reduction In Incidence Of Hospitalizations For Psychotic Episodes Through Early Identification & Intervention

You must be logged-in to view this content.

Reducing The Duration Of Untreated Psychosis & Its Impact In The U.S.: The STEP-ED Study

You must be logged-in to view this content.

‘Intelligent Assignment’ To Medicare Part D Plans Of Beneficiaries With Schizophrenia Could Save $150 Million Annually

You must be logged-in to view this content.

OmniComm Systems’ TrialMaster Selected By European Group For Research In Schizophrenia

You must be logged-in to view this content.

The Brief Adherence Rating Scale (BARS) Validated Against Electronic Monitoring In Assessing The Antipsychotic Medication Adherence Of Outpatients With Schizophrenia & Schizoaffective Disorder

You must be logged-in to view this content.

Towards A Pragmatic & Operational Definition Of Relapse In Schizophrenia: A Delphi Consensus Approach

You must be logged-in to view this content.

Addressing The Transition Of Care For Patients With Schizophrenia: A Case Study Approach

You must be logged-in to view this content.

Webinar Summary – Early Intervention In Psychosis: Benefits, Barriers, & Best Practices

You must be logged-in to view this content.

Early Intervention In Psychosis: Benefits, Barriers & Best Practices

Psychosis is ranked as one of the top three most disabling conditions worldwide, with a longer duration of untreated psychosis …

You must be logged-in to view this content.

“Sometimes It’s Difficult To Have A Normal Life”: Results From A Qualitative Study Exploring Caregiver Burden In Schizophrenia

You must be logged-in to view this content.

Exploratory Analysis Of Social Cognition & Neurocognition In Individuals At Clinical High Risk For Psychosis

You must be logged-in to view this content.

Webinar Summary – Facilitating Recovery In Schizophrenia: An Assertive Community Treatment Approach

You must be logged-in to view this content.

Facilitating Recovery In Schizophrenia: An Assertive Community Treatment Approach

Why is the concept of recovery important to patients with schizophrenia? What are some barriers to recovery? How can an …

You must be logged-in to view this content.

Effectiveness Of Continuity-Of-Care Programs To Reduce Time In Hospital In Persons With Schizophrenia

You must be logged-in to view this content.

Social Cognition As A Mediator Between Neurocognition & Functional Outcome In Individuals At Clinical High Risk For Psychosis

You must be logged-in to view this content.

Schizophrenia Genetics: Emerging Themes For A Complex Disorder

You must be logged-in to view this content.

Metabolic Wellness Considerations In Schizophrenia

You must be logged-in to view this content.

Webinar Summary – Does Relapse In Schizophrenia Cause Neurodegeneration? A Simulcast Debate & Webinar To Explore The Evidence

You must be logged-in to view this content.

Does Relapse In Schizophrenia Cause Neurodegeneration? A Simulcast Debate & Webinar To Explore The Evidence

There is a continuous debate in the mental health community around the progressive nature of schizophrenia as a disease: Is …

You must be logged-in to view this content.

Different & Shared Brain Volume Abnormalities In Late- & Early-Onset Schizophrenia

You must be logged-in to view this content.

Assertive Community Treatment: Bridging The Gaps In The Community

You must be logged-in to view this content.

Psychometric Properties Of The Questionnaire About The Process Of Recovery (QPR)

You must be logged-in to view this content.

Is Personal Recovery In Schizophrenia Predicted By Low Cognitive Insight?

You must be logged-in to view this content.

Fear Of Recurrence: Results Of A Randomized Trial Of Relapse Detection In Schizophrenia

You must be logged-in to view this content.

Design & Validation Of Standardized Clinical & Functional Remission Criteria In Schizophrenia

You must be logged-in to view this content.

The Nature Of Relapse In Schizophrenia

You must be logged-in to view this content.

Predicting Engagement With Services For Psychosis: Insight, Symptoms & Recovery Style

You must be logged-in to view this content.

Are There Clinically Useful Predictors & Early Warning Signs For Pending Relapse?

You must be logged-in to view this content.

Validating A Brief Version Of The Mental Health Recovery Measure For Individuals With Schizophrenia

You must be logged-in to view this content.

Why Are The Outcomes In Patients With Schizophrenia So Poor?

You must be logged-in to view this content.

The Onset & Offset Of Psychosis – & What Happens In Between

You must be logged-in to view this content.

Recovery In Psychosis: A Delphi Study With Experts By Experience

You must be logged-in to view this content.

Assessing Early Signs Of Relapse In Psychosis: Review & Future Directions

You must be logged-in to view this content.

Using Longitudinal Imaging To Map The ‘Relapse Signature’ Of Schizophrenia & Other Psychoses

You must be logged-in to view this content.

The Importance Of Adherence To Long-Term Success In Schizophrenia

You must be logged-in to view this content.

Systemwide Adoption Of Behavioral Health & Primary Care Integration Estimated To Save $26 Billion Annually

You must be logged-in to view this content.

Measurements Of Response, Remission & Recovery In Schizophrenia & Examples For Their Clinical Application

You must be logged-in to view this content.

Genetic Research Finds Schizophrenia Is Eight Distinct Disorders

You must be logged-in to view this content.